Vitale, M., Costabile, G., Testa, R., D'Abbronzo, G., Nettore, I
In STEP 1, STEP 3, and STEP 4, 3% of semaglutide patients in each study progressed to prediabetes, while 6% to 13% of patients progressed to prediabetes in the placebo group
Once the medication hits the market, its likely to be titrated meaning youll gradually increase the dose over time
During the initial weeks of semaglutide treatment, you may observe early signs of weight loss , but the most significant changes typically occur after a few months, as the medication reaches its full therapeutic potential
Faster dose escalation can accelerate appetite suppression but also increases side-effect risk, while slower increases allow your body to adapt but may delay results
Given the varied requirements of different communities and populations for health maintenance, antioxidant or mineral supplementation should be population-specific